Manufacturer record

Adroit Pharmaceuticals Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

7 batches manufactured by Adroit Pharmaceuticals Pvt. Ltd (Maharashtra) were declared Not of Standard Quality between April 2020 and December 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

7 records linked to Adroit Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
7Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Apr 2020 to Dec 2023

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

7
NSQ batches since 2020
5
Products affected
Related substances
Most common failure
Dec 2023
Latest alert

Flagged batches per year

2020 · 12022 · 22023 · 4

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
MULTIVITAMIN TABLETS NFI TN2212142Mfg 2022-12 · Exp 2024-02 Assay of vitamin D3 and DescriptionAssay CDL KolkataCDSCO lab Dec 2023
Ondansetron Tablets IP UP2212192Mfg 2022-12 · Exp 2024-11 Dissolution TestDissolution RDTL ChandigarhCDSCO lab Sep 2023
DICLOFENAC SODIUM TABLETS I.P.50 mg TS7464Mfg 2022-11 · Exp 2024-10 Test for Disintegration (Acid Stage)Disintegration CDTL HyderabadCDSCO lab Jun 2023
DICLOFENAC SODIUM TABLETS I.P. 50 mg TS7463Mfg 2022-11 · Exp 2024-10 Disintegration (Acid Stage)Disintegration CDTL HyderabadCDSCO lab Feb 2023
Domperidone Tablets I.P. 10 mg 2110138Mfg 2021-10 · Exp 2023-09 Related SubstancesRelated substances CDL KolkataCDSCO lab Aug 2022
Domperidone Tablets I.P. 10 mg 2105031Mfg 2021-05 · Exp 2023-04 Related SubstancesRelated substances CDL KolkataCDSCO lab Feb 2022
Salbutamol Sulphate Tablets I.P. 7193Mfg 2018-12 · Exp 2020-11 Related SubstancesRelated substances CDL KolkataCDSCO lab Apr 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.